fullerene c60 has been researched along with Cancer of Pancreas in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (71.43) | 24.3611 |
2020's | 2 (28.57) | 2.80 |
Authors | Studies |
---|---|
Bałaban, J; Chwalibog, A; Daniluk, K; Sawosz, E; Sosnowska, M; Strojny, B; Szczepaniak, J; Wierzbicki, M; Wójcik, B; Zielińska-Górska, M | 1 |
Curley, SA; Malarz, K; Mrozek-Wilczkiewicz, A; Musioł, R; Serda, M; Wojtyniak, M | 1 |
Anderson, AO; Corr, SJ; Curley, SA; Krzykawska-Serda, M; Law, J; Newton, JM; Nguyen, L; Sachdeva, S; Serda, M; Ware, MJ; Wilson, LJ | 1 |
Moldoveanu, I; Stanciu Gavan, C; Stefan-van Staden, RI | 1 |
Chen, C; Guo, M; Huynh, T; Kang, SG; Lu, Y; Pan, Y; Wang, L; Yang, Z; Zhao, Y; Zhou, R | 1 |
Brown, AP; Chung, EJ; Citrin, DE; Mitchell, JB; Shankavaram, UT; Shield, WP; Sowers, AL; Thetford, A; Urick, ME | 1 |
Chen, C; Huynh, T; Kang, SG; Liu, Y; Meng, H; Sun, B; Xing, G; Yang, P; Zhao, L; Zhao, Y; Zhou, G; Zhou, R | 1 |
7 other study(ies) available for fullerene c60 and Cancer of Pancreas
Article | Year |
---|---|
Effects of Metallic and Carbon-Based Nanomaterials on Human Pancreatic Cancer Cell Lines AsPC-1 and BxPC-3.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Survival; Diamond; Fullerenes; Gene Expression Regulation, Neoplastic; Gold; Graphite; Humans; Nanostructures; Neoplasm Proteins; Pancreatic Neoplasms; Platinum; Silver | 2021 |
Glycofullerenes as non-receptor tyrosine kinase inhibitors- towards better nanotherapeutics for pancreatic cancer treatment.
Topics: Agammaglobulinaemia Tyrosine Kinase; Autophagy; Cell Cycle Checkpoints; Cell Line, Tumor; Fullerenes; Heme Oxygenase-1; Humans; Oxidation-Reduction; Pancreatic Neoplasms; Protein Corona; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-fyn; Reactive Oxygen Species; Surface Properties; Tumor Suppressor Protein p53 | 2020 |
Development of photoactive Sweet-C
Topics: Adenocarcinoma; Antibodies; Antineoplastic Agents; Cell Line, Tumor; Cell Nucleus; Cell Survival; Cell- and Tissue-Based Therapy; Fullerenes; Glycoconjugates; Humans; Pancreatic Neoplasms; Pancreatic Stellate Cells; Photochemotherapy; Photosensitizing Agents | 2018 |
Molecular recognition of HER-1 in whole-blood samples.
Topics: Biosensing Techniques; Diamond; ErbB Receptors; Fullerenes; Gastrointestinal Neoplasms; Graphite; Humans; Lung Neoplasms; Nanostructures; Pancreatic Neoplasms | 2014 |
Gd-Metallofullerenol Nanomaterial Suppresses Pancreatic Cancer Metastasis by Inhibiting the Interaction of Histone Deacetylase 1 and Metastasis-Associated Protein 1.
Topics: Amino Acid Sequence; Antineoplastic Agents; Cell Line, Tumor; Cell Movement; Fullerenes; Gadolinium; GPI-Linked Proteins; Histone Deacetylase 1; Histone Deacetylases; Humans; Molecular Sequence Data; Nanoparticles; Neoplasm Metastasis; Pancreatic Neoplasms; Protein Binding; Repressor Proteins; Trans-Activators | 2015 |
Evaluation of the fullerene compound DF-1 as a radiation protector.
Topics: Adenocarcinoma; Animals; Bone Marrow; Cells, Cultured; Fibroblasts; Fullerenes; Humans; Hypoxia; Injections, Intraperitoneal; Male; Mice; Mice, Inbred C57BL; Nanoparticles; Pancreatic Neoplasms; Prostatic Neoplasms; Radiation Injuries; Radiation-Protective Agents; Whole-Body Irradiation | 2010 |
Molecular mechanism of pancreatic tumor metastasis inhibition by Gd@C82(OH)22 and its implication for de novo design of nanomedicine.
Topics: Animals; Catalytic Domain; Drug Design; Extracellular Matrix; Fullerenes; Gadolinium; Humans; Hydrogen Bonding; Ions; Ligands; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Mice; Nanomedicine; Nanoparticles; Neoplasm Metastasis; Neoplasm Transplantation; Neovascularization, Pathologic; Pancreatic Neoplasms; Zinc | 2012 |